Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Exact Sciences Corp (EXAS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013850
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates a laboratory facility in Madison, Wisconsin to process Cologuard tests. Exact is headquartered in Madison, Wisconsin, the US.

Exact Sciences Corp (EXAS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exact Sciences Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exact Sciences Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exact Sciences Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exact Sciences Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Exact Sciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exact Sciences Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 10
Partnerships 11
Exact Sciences Amends Licensing Agreement with Mayo Clinic 11
Exact Sciences Expands Licensing Agreement With Mayo Clinic 12
MDxHealth Enters Into Licensing Agreement With Exact Sciences 13
MDxHealth Enters into Agreement with Exact Sciences 14
Equity Offering 15
Exact Sciences Raises USD245 Million in Public Offering of Shares 15
Exact Sciences Prices Public Offering of Shares for USD132 Million 17
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 18
Exact Sciences Prices Public Offering of Shares for USD103 Million 19
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 20
Exact Sciences Completes Public Offering Of Shares For US$78 Million 22
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 23
Exact Sciences Completes Underwritten Public Offering Of Common Stock For US$29 Million 24
Exact Sciences Corp – Key Competitors 26
Exact Sciences Corp – Key Employees 27
Exact Sciences Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests 29
Feb 21, 2017: Exact Sciences reports lower Q4 net loss, provides outlook for 2017 30
Feb 24, 2016: Exact Sciences Reports Fourth Quarter and Full Year 2015 Results 31
Jan 11, 2016: Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results 32
Corporate Communications 33
Nov 08, 2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer 33
Product News 34
02/25/2016: Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network Service 34
02/23/2016: Modeling Data Supports Cologuard Use Every Three Years 35
02/19/2016: Routine Annual Screening for Colorectal Cancer Not Achieved by Fecal Blood Tests 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Exact Sciences Corp, Medical Equipment, Key Facts, 2016 2
Exact Sciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Exact Sciences Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exact Sciences Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exact Sciences Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exact Sciences Corp, Deals By Market, 2011 to YTD 2017 8
Exact Sciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 10
Exact Sciences Amends Licensing Agreement with Mayo Clinic 11
Exact Sciences Expands Licensing Agreement With Mayo Clinic 12
MDxHealth Enters Into Licensing Agreement With Exact Sciences 13
MDxHealth Enters into Agreement with Exact Sciences 14
Exact Sciences Raises USD245 Million in Public Offering of Shares 15
Exact Sciences Prices Public Offering of Shares for USD132 Million 17
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 18
Exact Sciences Prices Public Offering of Shares for USD103 Million 19
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 20
Exact Sciences Completes Public Offering Of Shares For US$78 Million 22
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 23
Exact Sciences Completes Underwritten Public Offering Of Common Stock For US$29 Million 24
Exact Sciences Corp, Key Competitors 26
Exact Sciences Corp, Key Employees 27
Exact Sciences Corp, Subsidiaries 28

★海外企業調査レポート[Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NiSource Inc (NI):企業の財務・戦略的SWOT分析
    NiSource Inc (NI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Northwest Pipe Co (NWPX):企業の財務・戦略的SWOT分析
    Northwest Pipe Co (NWPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hays plc:企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • PT Central Proteina Prima Tbk (CPRO):企業の財務・戦略的SWOT分析
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • St. James’S Place Plc
    St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report Summary St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • First Gen Corp (FGEN):電力:M&Aディール及び事業提携情報
    Summary First Gen Corp (First Gen) a subsidiary of First Philippine Holding Corporation is a producer and distributor of electric power. It undertakes activities such as power generation, power distribution, infrastructure, manufacturing, and property development. The company together with its subsi …
  • Danone SA:戦略・SWOT・企業財務分析
    Danone SA - Strategy, SWOT and Corporate Finance Report Summary Danone SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Mosenergo (MSNG):電力:M&Aディール及び事業提携情報
    Summary Mosenergo, a subsidiary of Gazprom Energoholding LLC, is a power utility. It generates electricity and thermal energy using natural gas, coal, fuel oil, and diesel sources. The company owns and operates power plants: TPP-20, SDPP-3, TPP-9, SPP-1, TPP-21, TPP-8, TPP-11, TPP-16, TPP-12, TPP-17 …
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • Putzmeister Holding GmbH:企業の戦略・SWOT・財務情報
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Centrotec Sustainable AG (CEV):企業の財務・戦略的SWOT分析
    Summary Centrotec Sustainable AG (Centrotec) is an energy company that provides energy saving systems. The company provides products such as medical technology plastics, climate systems, gas flue systems and engineering plastics, among others. It also offers ventilation with heat recovery, heating s …
  • UMW Holdings Berhad (UMW):石油・ガス:M&Aディール及び事業提携情報
    Summary UMW Holdings Bhd (UMW) is a diversified company. The company operates through its business divisions such as automotive, equipment, manufacturing and engineering, and oil and gas. Its automotive business manufactures, assembles, markets and distributes passenger cars and commercial vehicles. …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Unitika Ltd (3103):企業の財務・戦略的SWOT分析
    Unitika Ltd (3103) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • ThreeD Capital:企業のM&A・事業提携・投資動向
    ThreeD Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThreeD Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Smiths Group plc:企業の戦略・SWOT・財務情報
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆